Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Thalidomide“
Suchtreffer
Begriffe & Kennungen
Thalidomide BMS (previously Thalidomide Celgene) · 4.5 · Medicinal products known to cause peripheral neuropathy
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.5 · Multiple dose administration of 200 mg thalidomide q.d. for 4 days had no effect on the international normaliz
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.5 · Thalidomide does not interact with digoxin. In 18 healthy male volunteers, multiple dose administration of 200
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.5 · Thalidomide does not interact with hormonal contraceptives. In 10 healthy women, the pharmacokinetic profiles
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.5 · Thalidomide has sedative properties, thus may enhance the sedation induced by anxiolytics, hypnotics, antipsyc
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.5 · Thalidomide is a poor substrate for cytochrome P450 isoenzymes and therefore clinically important interactions
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 Undesirable effects · 1
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · 12 System Organ Class Frequency Adverse reaction
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · 13 Table 4: Comparison of haematological disorders for the melphalan, prednisone (MP) and melphalan, prednison
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · 14 Reporting of suspected adverse reactions
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) AML and MDS were reported in one clinical st
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Additional adverse reactions from post-marketing experience with thalidomide and not seen in the pivotal study
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Allergic reactions and severe skin reactions Cases of allergic reactions including angioedema, anaphylactic re
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Blood and lymphatic system disorders Adverse reactions for haematological disorders are provided compared to t
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Common Pneumonia Infections and infestations Severe infections (e.g. fatal sepsis including septic Not Known s
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Description of selected adverse reactions
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Elderly population
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Frequencies are defined as: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1000 to < 1/100);
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · In addition to the adverse reactions outlined above, thalidomide in combination with dexamethasone in other cl
Eintrag öffnen